Skip to main content
TipRanks
Go Ultimate75% OFF

Lyell Immunopharma (LYEL) Balance Sheet

163 Followers

Lyell Immunopharma Balance Sheet

Lyell Immunopharma's total assets for Q3 2026 were $273.85M, a decrease of 11.99% from the previous quarter. LYEL total liabilities were $81.13M for the fiscal quarter, a 4.91% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 340.05M$ 490.86M$ 750.03M$ 937.56M$ 1.13B
$ 91.85M$ 108.03M$ 95.08M$ 104.31M$ 197.62M
$ 248.20M$ 382.82M$ 654.95M$ 833.25M$ 929.79M

Currency in USD

Lyell Immunopharma Liabilities to Assets

0400M800M1.2B8 %16 %24 %32 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets